CANNABIS-BASED PHARMACEUTICAL PRODUCTS THAT SPEAK THE LANGUAGE OF DOCTORS.
For Illustration Purposes Only
Alvit LCS Pharma was founded in 2014 with the goal of researching and developing cannabis based pharmaceutical products that speak the language of doctors. Since then, the company has successfully developed a broad line of Pharma grade cannabis products that include various types of tablets, sprays, suppositories, and more. Several of these products have already completed or been approved for clinical trials in Israel.
WE CONTROL THE ENTIRE LIFE CYCLE OF THE CANNABIS DRUG DEVELOPMENT PROCESS.
Alvit is a vertically integrated company which controls the entire life cycle of the cannabis drug development process, including controlled cultivation of proprietary cannabis clones under EU-GMP conditions.
IN ADDITION TO PRODUCT R&D IN ISRAEL, ALVIT HAS EMBARKED ON SEVERAL OTHER INITIATIVES INTERNATIONALLY.
Intelicanna is a cannabis cultivation facility in Israel that is publicly traded on the Tel Aviv Stock Exchange (TLV:INTL). Intelicanna already has sales agreements in place for the Israeli market and is looking to pursue additional opportunities internationally.
Mycolivia is a Medicinal Mushroom Company that combines cannabis and mushrooms to create more effective treatments for the symptoms of certain indications. The company is currently engaged in an IPO process to go public on the CSE in Canada.
Alvit Germany was established for the purpose of marketing and distribution Alvit’s line of flowers, oils, and products in the German marketplace.
Alvit is pursuing additional international opportunities that are in various stages of development.
Alvit received a letter of intent in Malta that includes land to construct a 5,000 sqm GACP cultivation and EU-GMP production facility with licenses to import, cultivate, process, manufacture, sell, and export medical cannabis to the European market.